As drug development continues to evolve, ensuring the safety of potential therapeutic agents is a critical component. hERG plays a key role in this process as it encodes a potassium channel involved in the regulation of the heart's electrical activity. hERG channel dysfunction can lead to severe cardiac arrhythmias and even sudden death. CD ComputaBio stands at the forefront of this innovative service, providing the pharmaceutical industry with state-of-the-art solutions to improve drug safety. https://cadd.computabio.co...

Only people mentioned by VivianSmith in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vivian Smith, click on at the bottom under it